Quick Answer
Neither procedure is universally superior — the better choice depends entirely on the individual patient’s anatomy and prescription. EVO ICL is generally preferred for patients with high myopia (above -8D), thin corneas, or dry eye conditions. LASIK is typically preferred for mild to moderate prescriptions in patients with adequate corneal tissue and no significant dry eye. Both procedures achieve high rates of 20/20 or better uncorrected vision.
Detailed Explanation
Comparing EVO ICL and LASIK requires understanding what each procedure changes — and what it leaves intact.
LASIK: reshaping the cornea
LASIK uses a laser to permanently reshape the corneal stroma, flattening it to reduce the eye’s refractive error. A hinged flap is created in the corneal surface first, the laser ablation is applied, and the flap is repositioned. LASIK is a cornea-destructive procedure in the sense that it permanently removes corneal tissue.
This creates two constraints: 1. Corneal thickness. A minimum residual stromal bed of 250 to 300 microns must remain after ablation to maintain structural integrity. Thin corneas limit the prescription that can safely be corrected. 2. Dry eye. LASIK severs corneal nerves during flap creation. These nerves partially regenerate over 6 to 12 months, but the temporary nerve disruption reduces tear secretion. Patients with pre-existing dry eye are at high risk for significant symptom worsening.
EVO ICL: additive, not subtractive
EVO ICL adds a lens inside the eye without modifying the cornea. No corneal tissue is removed. No corneal nerves are severed. The natural crystalline lens remains intact.
Because the procedure is additive:
- Corneal thickness is irrelevant to the correction
- Dry eye is not worsened by the procedure
- The correction can address prescriptions far outside LASIK’s safe range
- The lens can be removed if needed
Head-to-head clinical comparison:
| Factor | EVO ICL | LASIK | |—|—|—| | Prescription range | -3D to -20D (myopia) | -1D to -12D (typical safe range) | | Corneal requirement | None | Minimum residual bed of 250-300 microns | | Dry eye impact | Neutral to slightly improved | Can worsen existing dry eye | | Reversibility | Yes — fully reversible | No — permanent | | Night vision quality | Generally superior for high Rx | Acceptable for low to moderate Rx | | UV protection | Built into Collamer material | Not provided by procedure | | Recovery speed | Vision stable within 24 hours | Vision stable within 24-48 hours | | Procedure duration | 20-30 minutes per eye | 10-15 minutes per eye | | Cost | $4,000-$5,500/eye | $2,000-$3,000/eye |
Visual quality at high prescriptions:
At prescriptions above -6D, EVO ICL consistently outperforms LASIK on objective measures of visual quality — particularly contrast sensitivity and night vision performance. When LASIK corrects a high prescription, it requires removing more corneal tissue, which can induce higher-order aberrations that reduce optical quality. EVO ICL does not alter the corneal optics, preserving the eye’s natural aberration profile.
For a full directory of surgeons recognized for clinical excellence in EVO ICL, visit the EVO ICL Awards page.
When LASIK is the better choice:
For patients with mild to moderate myopia (up to -6D), adequate corneal thickness, no significant dry eye, and a lower budget, LASIK is a well-validated, efficient procedure. The corneal modification required for low prescriptions is minimal, and outcomes are highly predictable.
When EVO ICL is the better choice:
- Prescription above -8D (LASIK becomes progressively less predictable and higher risk)
- Corneal thickness that places the residual stromal bed below the safe threshold after ablation
- Pre-existing dry eye syndrome
- Patients who value reversibility
- High-performance vision demands (professional athletes, pilots, surgeons) where optical quality matters more than cost
Important Considerations
Some patients qualify for both procedures. In these cases, the decision comes down to personal priorities: cost, reversibility, optical quality expectations, and tolerance for intraocular surgery versus corneal surgery.
A critical point that many patients miss: being “eligible” for LASIK does not mean LASIK is the optimal choice. A patient with -7D of myopia and borderline corneal thickness technically may qualify for LASIK, but the outcome quality and long-term safety profile of EVO ICL in that patient profile is generally superior.
Conversely, patients who do not meet EVO ICL candidacy requirements — including those who lack sufficient anterior chamber depth or have contraindicated medical conditions — should not pursue EVO ICL simply because it sounds appealing. Candidacy must be established through comprehensive preoperative examination.
It is also worth noting that EVO ICL and supplemental laser treatment (LASIK or PRK) are sometimes combined in patients who have residual refractive error after ICL implantation. This “bioptics” approach allows highly customized correction for patients with very complex refractive errors.
What to Do Next
The first step is a comprehensive preoperative evaluation that measures both corneal parameters (for LASIK eligibility) and anterior chamber parameters (for EVO ICL eligibility). Many leading practices offer a combined evaluation that tells you definitively which procedure you qualify for — and which is optimal.
Review Who Is Not a Good Candidate for EVO ICL? to understand the specific disqualifying criteria for EVO ICL before scheduling a consultation.
Related Questions
What about EVO ICL versus PRK? PRK is another laser option worth comparing. See EVO ICL vs PRK: Which Is Better? for a direct comparison of these two alternatives.
What are the risks specific to EVO ICL? See What Are the Risks of EVO ICL Surgery? for a complete review of procedure-specific complications.
What does EVO ICL cost compared to LASIK? Get the full cost breakdown in How Much Does EVO ICL Cost?.